• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“不仅仅是美沙酮,特蕾西”:澳大利亚阿片类药物替代治疗环境中引入丙型肝炎治疗后服务使用者身份的转变

'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.

作者信息

Rance Jake, Treloar Carla

出版信息

Addiction. 2014 Mar;109(3):452-9. doi: 10.1111/add.12392.

DOI:10.1111/add.12392
PMID:24678545
Abstract

AIMS

To explore identity transformation among service users attending opiate substitution therapy (OST) clinics following the introduction of hepatitis C (HCV) care and treatment.

DESIGN

An interview-based substudy of the Australian ETHOS (Enhancing Treatment for Hepatitis C in Opiate Substitution Settings) project.

SETTING

Three OST clinics and one community health centre (operating a public OST) in New South Wales, Australia. Participants were interviewed at the recruitment sites.

PARTICIPANTS

The sample consisted of 57 OST service users concurrently living with HCV, 16 staff, including specialist HCV clinicians, and three peer-support workers, employed on the ETHOS project.

MEASUREMENTS

Semi-structured interviews.

FINDINGS

Service-user participants largely welcomed the introduction of HCV treatment as a practical, clinical intervention that also intimated a more comprehensive, holistic form of care. Negative stereotypes characteristic of OST settings-of limited, routinized clinical exchanges and minimal social-care interaction-were unsettled, opening up the possibility of new relations between staff and service users. The shift in the dynamic of the clinical encounter to address health in addition to dependence appeared to catalyse transformative possibilities not only for the therapeutic alliance but also for service-user understandings of self and identity.

CONCLUSION

Trial introduction of HCV care and treatment in selected Australian opiate substitution therapy (OST) clinics may have facilitated alternative, 'non-addict' identities to emerge from a clinical setting where the stigmatizing figure of 'the drug user' has traditionally prevailed.

摘要

目的

探讨在引入丙型肝炎(HCV)护理与治疗后,接受阿片类药物替代疗法(OST)门诊治疗的服务对象的身份转变情况。

设计

澳大利亚ETHOS(在阿片类药物替代治疗环境中加强丙型肝炎治疗)项目的一项基于访谈的子研究。

地点

澳大利亚新南威尔士州的三家OST门诊和一家社区卫生中心(提供公共OST服务)。研究对象在招募地点接受访谈。

参与者

样本包括57名同时感染HCV的OST服务对象、16名工作人员(包括HCV专科临床医生)以及3名受雇于ETHOS项目的同伴支持工作者。

测量方法

半结构化访谈。

研究结果

服务对象参与者普遍欢迎引入HCV治疗,认为这是一种切实可行的临床干预措施,也意味着更全面、整体的护理形式。OST环境中常见的负面刻板印象——有限且常规化的临床交流以及极少的社会护理互动——被打破,为工作人员与服务对象之间建立新关系创造了可能性。临床诊疗中除了关注成瘾问题还关注健康的这种动态转变,似乎不仅促进了治疗联盟的转变,也促使服务对象对自我和身份的认知发生转变。

结论

在澳大利亚部分阿片类药物替代疗法(OST)门诊试行引入HCV护理与治疗,可能促使在传统上以“吸毒者”这一污名化形象为主导的临床环境中出现替代性的“非成瘾者”身份。

相似文献

1
'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.“不仅仅是美沙酮,特蕾西”:澳大利亚阿片类药物替代治疗环境中引入丙型肝炎治疗后服务使用者身份的转变
Addiction. 2014 Mar;109(3):452-9. doi: 10.1111/add.12392.
2
The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.场所政治学:在阿片类物质替代诊所提供丙型肝炎治疗的问题化。
Soc Sci Med. 2012 Jan;74(2):245-53. doi: 10.1016/j.socscimed.2011.10.003. Epub 2011 Nov 20.
3
How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.如何在阿片类药物治疗诊所建立值得信赖的丙型肝炎服务?对同一地点的客户和卫生工作者进行的定性研究。
Int J Drug Policy. 2014 Sep;25(5):865-70. doi: 10.1016/j.drugpo.2014.01.011. Epub 2014 Jan 26.
4
Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.澳大利亚新南威尔士州阿片类药物替代治疗环境中丙型肝炎联合治疗服务的患者及工作人员体验。
Drug Alcohol Depend. 2013 Dec 1;133(2):529-34. doi: 10.1016/j.drugalcdep.2013.07.023. Epub 2013 Aug 2.
5
Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.阿片类物质替代治疗中丙型肝炎治疗的接受和提供:客户和卫生专业人员的看法。
J Viral Hepat. 2010 Dec;17(12):839-44. doi: 10.1111/j.1365-2893.2009.01250.x.
6
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.针对接受阿片类药物替代治疗的吸毒者及社区卫生诊所中的丙型肝炎病毒感染者的治疗:ETHOS研究。
Addiction. 2016 Feb;111(2):311-9. doi: 10.1111/add.13197. Epub 2015 Nov 25.
7
A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.澳大利亚新南威尔士州监狱中寻求和停止阿片类药物替代治疗的原因的定性研究。
Drug Alcohol Rev. 2017 May;36(3):305-310. doi: 10.1111/dar.12442. Epub 2016 Jun 21.
8
Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.墨西哥提华纳提供阿片类药物替代疗法的成本。
Harm Reduct J. 2018 May 23;15(1):28. doi: 10.1186/s12954-018-0234-x.
9
Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.南非茨瓦内市阿片类药物替代疗法服务使用者的保留率。
Afr J Prim Health Care Fam Med. 2023 Jan 30;15(1):e1-e10. doi: 10.4102/phcfm.v15i1.3392.
10
Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.在一项快速阿片类药物替代治疗可行性随机对照试验中增强动机:一项嵌套式定性研究
Subst Abuse Treat Prev Policy. 2014 Nov 18;9:44. doi: 10.1186/1747-597X-9-44.

引用本文的文献

1
Methadone Patient Access to Collaborative Treatment: Protocol for a Pilot and a Randomized Controlled Trial to Establish Feasibility of Adoption and Impact on Methadone Treatment Delivery and Patient Outcomes.美沙酮患者获得联合治疗:一项试点及随机对照试验的方案,以确定采用的可行性及其对美沙酮治疗实施和患者结局的影响。
JMIR Res Protoc. 2025 Apr 15;14:e69829. doi: 10.2196/69829.
2
Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis.未来的去向:在一个无丙型肝炎病毒的全新世界里,使用直接抗病毒药物治愈丙型肝炎的患者的进展。一项主题分析。
Harm Reduct J. 2025 Jan 16;22(1):10. doi: 10.1186/s12954-024-01142-3.
3
Opportunities and Challenges Hepatitis C Testing and Treatment Access Experiences Among People in Methadone and Buprenorphine Treatment During COVID-19, Arizona, 2021.
2021年亚利桑那州新冠疫情期间接受美沙酮和丁丙诺啡治疗的人群中丙型肝炎检测与治疗可及性的机遇与挑战
AJPM Focus. 2022 Nov 5;2(1):100047. doi: 10.1016/j.focus.2022.100047. eCollection 2023 Mar.
4
Should I Stay or Should I Go? A Qualitative Exploration of Stigma and Other Factors Influencing Opioid Agonist Treatment Journeys.我该留下还是离开?定性探讨影响阿片类激动剂治疗旅程的污名化和其他因素。
Int J Environ Res Public Health. 2023 Jan 14;20(2):1526. doi: 10.3390/ijerph20021526.
5
Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study.出狱后兴奋剂使用障碍诊断和阿片类激动剂治疗配给:一项队列研究。
Subst Abuse Treat Prev Policy. 2022 Nov 24;17(1):77. doi: 10.1186/s13011-022-00504-z.
6
Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review.物质使用中的身份转变是康复的途径,以及丙型肝炎治疗的潜力:系统评价。
Addiction. 2023 Mar;118(3):425-437. doi: 10.1111/add.16031. Epub 2022 Sep 5.
7
Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world.未来的目的地和社会包容范围审查:使用直接作用抗病毒药物治愈丙型肝炎(HCV)的人如何在一个新的无 HCV 世界中取得进展。
Subst Abuse Treat Prev Policy. 2022 Jun 8;17(1):45. doi: 10.1186/s13011-022-00475-1.
8
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.在加拿大注射用阿片类激动剂治疗环境中,使用持续释放右旋苯丙胺治疗兴奋剂使用障碍:病例报告。
Harm Reduct J. 2021 May 20;18(1):57. doi: 10.1186/s12954-021-00500-9.
9
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis.阿片类激动剂治疗与注射吸毒者丙型肝炎感染的检测、治疗接受和治疗结局的关系:系统评价和荟萃分析。
Clin Infect Dis. 2021 Jul 1;73(1):e107-e118. doi: 10.1093/cid/ciaa612.
10
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.建立以患者为中心的医疗服务提供者关系:接受注射类阿片激动剂治疗者的经验定性研究。
Subst Abuse Treat Prev Policy. 2020 Jan 20;15(1):7. doi: 10.1186/s13011-020-0253-y.